TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS | MicrobiomeTrials← Back to trialsNCT07893964
TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2028-10
Enrollment target: 100 participants Locations- McMaster University, Hamilton, Ontario, Canada
- Queen's University, Kingston, Ontario, Canada
- Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Autism Spectrum DisorderTherapy
The project aims to develop and implement the Strategies for Toddler Autism spectrum disorder(ASD) with Remote-therapy (…
Shanghai, ChinaEst. completion Dec 30, 2026
Neuropsychiatric DisorderNeurological DisorderNeurodevelopmental DisorderSleep
Background:
\- Many psychiatric, behavioral, and developmental disorders are genetic. This means that they tend to run …
Bethesda, United StatesCompleted Jul 24, 2025
Smith-Magenis SyndromeAutism Spectrum Disorder
Autism Spectrum Disorders (ASD) are a neurodevelopmental disorder. Their prevalence is estimated at around 0.4% of the g…
Bron, FranceEst. completion Apr 2027